Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jan 2007

Zhang Jian Gang, Eguchi Junichi, Kruse Carol A, Gomez German G, Fakhrai Habib, Schroter Stephanie, Ma Wenxue, Hoa Neil, Minev Boris, Delgado Christina, Wepsic H Terry, Okada Hideho, Jadus Martin R

Abstract excerpt

PURPOSE: Allogeneic glioma cell lines that are partially matched to the patient at class I human leukocyte antigen (HLA) loci and that display tumor-associated antigens (TAA) or antigenic precursors [tumor antigen precursor proteins (TAPP)] could be used for generating whole tumor cell vaccines or, alternatively, for extraction of TAA peptides to make autologous dendritic cell vaccines. EXPERIMENTAL DESIGN:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MHC Class I

Share to Glioma

Share to HLA Antigens

Share to Immunotherapy

Share to Microscopy, Fluorescence

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 17255279
DOI: 10.1158/1078-0432.CCR-06-1576
PMCID: PMC4030524

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.PMID 17255279Read ↗

Cancer Vaccines: Antigen Selection StrategySemantic proximity Read ↗

Identification of human tumor antigens and its implications for diagnosis and treatment of cancerSemantic proximity Read ↗

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in GlioblastomaSemantic proximity Read ↗

Human tumor antigens are ready to fly.Semantic proximity Read ↗

T-Cell Epitope Discovery for Therapeutic Cancer Vaccines.Semantic proximity Read ↗

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.Semantic proximity Read ↗

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.Semantic proximity Read ↗

A novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneitySemantic proximity Read ↗

Analysis of tumor-derived and cross-presented peptide antigens defines improved immunotherapeutic strategiesSemantic proximity Read ↗

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor CellSemantic proximity Read ↗

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccinationSemantic proximity Read ↗

Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.